CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Purple Biotech Ltd   (PPBT)
Other Ticker:  
 

Purple Biotech Ltd 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Purple Biotech Ltd in the forth quarter 2022?
Purple Biotech Ltd achieved a return on average equity (ROE) of 46.2 % in its forth quarter 2022, this is above PPBT's average return on equity of 41.01%.
Purple Biotech Ltd shareholder's equity over the 12 months ending in its forth quarter 2022 are valued at $47 million

ROE has advanced compared to 35.79% in the third quarter 2022, due to net income growth.

Within the Major Pharmaceutical Preparations industry 21 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the third quarter 2022 from 0 to 192.

What is ROE?



Return On Equity (Dec 31 2022)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Dec 31 2021)
IV. Quarter
Y / Y Equity Change -27.66 % -27.66 % -27.66 % -27.66 % -
Y / Y Net Income Change 17.83 % - - - -34.22 %
Net Income (TTM) in Millions 22 18 18 18 18
Return On Equity (TTM) 46.2 % 35.79 % 32.92 % 30.47 % 28.37 %
PPBT's Total Ranking # 192 # 0 # 0 # 0 # 651
Equity (TTM) in Millions 47 47 47 47 65
Seq. Equity Change 0 % 0 % 0 % -27.66 % 0 %
Seq. Net Income Change - - - - -

Back to PPBT Management Effectiveness >> PPBT's 5 Years Annual ROE >> Compare PPBT ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry # 22
Sector # 41
Overall # 192

Return On Equity Statistics
High Average Low
54.27 %
41.01 %
28.37 %
(Dec 31 2019)   (Dec 31 2021)


PPBT Annual Return On Equity (Dec 31 2022)
2022		 (Dec 31 2021)
2021		 (Dec 31 2020)
2020		 (Dec 31 2019)
2019		 (Dec 31 2018)
2018
Total Equity in Millions 47 65 80 11 11
Y / Y Equity Change -27.66 % -18.36 % 634.43 % -1.32 % -
Net Income in Millions 22 18 28 6 6
Y / Y Net Income Change 17.83 % -34.22 % 376.4 % 5.82 % -
Return On Equity 46.2 % 28.37 % 35.2 % 54.27 % 50.61 %

Back to PPBT Management Effectiveness >> PPBT's 5 Years Annual ROE >> Compare PPBT ROE to its Competitors




Annual Roe Comment
In 2022 ROE improved to 46.2 % compared to the previous year, due to net income growth.


More Return On Equity Ratios
Major Pharmaceutical Preparations Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
PPBT's' Return on Equity at Yahoo Finance
PPBT's Roe Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Roe for PPBT's Competitors
Return On Equity for Purple Biotech Ltd 's Suppliers
Roe for PPBT's Customers




Companies with similar Return On Equity at Dec 31 2022, within Healthcare Sector ROE
Idexx Laboratories Inc  124.52 %
Chimerix inc   113.54 %
Halozyme Therapeutics Inc   98.57 %
Biomx Inc   94.11 %
Davita Inc   92.73 %
Ocuphire Pharma Inc   79.52 %
Vaso Corporation  78.32 %
Abbvie Inc   73.67 %
Assertio Holdings inc   72.98 %
Kiniksa Pharmaceuticals Ltd   66.68 %
Denali Therapeutics Inc   65.68 %
Dynavax Technologies Corporation  65.38 %
Dariohealth Corp   64.99 %
Avid Bioservices Inc   64.69 %
Eli Lilly And Company  63.95 %
Aptevo Therapeutics Inc   63.08 %
Maravai Lifesciences Holdings Inc   61.82 %
Medpace Holdings Inc   60.42 %
Harmony Biosciences Holdings inc   60.10 %
Shockwave Medical Inc   59.99 %
Chemomab Therapeutics Ltd   58.23 %
Sensus Healthcare Inc   53.08 %
Molecular Partners Ag  50.11 %
Moderna Inc   46.34 %
Check cap Ltd   46.25 %
Purple Biotech Ltd   46.20 %
Zoetis Inc   46.13 %
Fusion Pharmaceuticals Inc   46.13 %
National Research Corporation  43.88 %
Tenet Healthcare Corp  43.83 %

Date modified: 2023-03-23T13:12:32+00:00



Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071